Richard Festenstein

3.7k total citations
37 papers, 2.7k citations indexed

About

Richard Festenstein is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Richard Festenstein has authored 37 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 9 papers in Genetics. Recurrent topics in Richard Festenstein's work include Genomics and Chromatin Dynamics (15 papers), Genetic Neurodegenerative Diseases (11 papers) and Epigenetics and DNA Methylation (7 papers). Richard Festenstein is often cited by papers focused on Genomics and Chromatin Dynamics (15 papers), Genetic Neurodegenerative Diseases (11 papers) and Epigenetics and DNA Methylation (7 papers). Richard Festenstein collaborates with scholars based in United Kingdom, United States and Germany. Richard Festenstein's co-authors include Dimitris Kioussis, Niall Dillon, Patrick J. Wijchers, Alexander Saveliev, Mauro Tolaini, Alain Verreault, Margaret Fox, Zoë Webster, C. M. Everett and Cihangir Yandım and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

Richard Festenstein

36 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Festenstein United Kingdom 25 2.1k 624 468 348 269 37 2.7k
Hirohiko Hohjoh Japan 29 1.8k 0.9× 349 0.6× 217 0.5× 336 1.0× 485 1.8× 70 3.0k
Jo Peters United Kingdom 31 2.6k 1.3× 2.0k 3.3× 355 0.8× 257 0.7× 152 0.6× 66 3.8k
Joel Schwartz United States 17 1.6k 0.8× 281 0.5× 793 1.7× 196 0.6× 459 1.7× 17 2.7k
Giuseppe Merla Italy 35 1.6k 0.8× 746 1.2× 168 0.4× 460 1.3× 117 0.4× 97 2.9k
Hitoshi Miyachi Japan 25 1.9k 0.9× 477 0.8× 251 0.5× 589 1.7× 347 1.3× 65 3.0k
Jean‐Philippe Hugnot France 28 2.6k 1.3× 263 0.4× 655 1.4× 103 0.3× 268 1.0× 62 3.4k
Kathleen A. Worringer United States 11 2.0k 1.0× 685 1.1× 221 0.5× 289 0.8× 133 0.5× 14 2.8k
Marlène Rio France 33 2.2k 1.1× 1.7k 2.7× 237 0.5× 225 0.6× 113 0.4× 112 3.5k
Sylvain Briault France 23 1.8k 0.9× 1.6k 2.5× 426 0.9× 187 0.5× 140 0.5× 64 3.1k
Nicole J. Francis United States 25 4.1k 2.0× 494 0.8× 443 0.9× 159 0.5× 670 2.5× 54 4.8k

Countries citing papers authored by Richard Festenstein

Since Specialization
Citations

This map shows the geographic impact of Richard Festenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Festenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Festenstein more than expected).

Fields of papers citing papers by Richard Festenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Festenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Festenstein. The network helps show where Richard Festenstein may publish in the future.

Co-authorship network of co-authors of Richard Festenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Festenstein. A scholar is included among the top collaborators of Richard Festenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Festenstein. Richard Festenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nethisinghe, Suran, Valeria Ricotti, Thomas Voit, et al.. (2023). A wearable motion capture suit and machine learning predict disease progression in Friedreich’s ataxia. Nature Medicine. 29(1). 86–94. 36 indexed citations
2.
Ricotti, Valeria, et al.. (2023). Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy. Nature Medicine. 29(1). 95–103. 42 indexed citations
3.
Ng, Roy Chun-Laam, Min Jian, Jason Shing-Cheong Kwan, et al.. (2020). Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer’s disease mouse model. Molecular Psychiatry. 26(10). 5669–5689. 66 indexed citations
4.
Zhang, Wei, et al.. (2016). Identification of a novel distal regulatory element of the humanNeuroglobingene by the chromosome conformation capture approach. Nucleic Acids Research. 45(1). 115–126. 21 indexed citations
5.
Libri, Vincenzo, Cihangir Yandım, Pui Pik Law, et al.. (2014). Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study. The Lancet. 384(9942). 504–513. 107 indexed citations
6.
Styś, Agnieszka, et al.. (2012). Transcription Elongation and Tissue-Specific Somatic CAG Instability. PLoS Genetics. 8(11). e1003051–e1003051. 43 indexed citations
7.
Wijchers, Patrick J. & Richard Festenstein. (2011). Epigenetic regulation of autosomal gene expression by sex chromosomes. Trends in Genetics. 27(4). 132–140. 124 indexed citations
8.
Guillemette, Benoît, Paul Drogaris, Kyoko Hiragami-Hamada, et al.. (2011). H3 Lysine 4 Is Acetylated at Active Gene Promoters and Is Regulated by H3 Lysine 4 Methylation. PLoS Genetics. 7(3). e1001354–e1001354. 153 indexed citations
9.
Hiragami-Hamada, Kyoko, Sheila Q. Xie, Alexander Saveliev, et al.. (2009). The molecular basis for stability of heterochromatin-mediated silencing in mammals. Epigenetics & Chromatin. 2(1). 14–14. 17 indexed citations
10.
Manderson, Anthony P., Francesco Carlucci, Peter J. Lachmann, et al.. (2006). The in vivoexpression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosus. Arthritis Research & Therapy. 8(3). R68–R68. 18 indexed citations
11.
Festenstein, Richard, et al.. (2005). Heterochromatin protein 1: a pervasive controlling influence. Cellular and Molecular Life Sciences. 62(23). 2711–2726. 112 indexed citations
12.
Saveliev, Alexander, et al.. (2003). DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing. Nature. 422(6934). 909–913. 205 indexed citations
13.
Azuara, Véronique, Karen Brown, Ruth Williams, et al.. (2003). Heritable gene silencing in lymphocytes delays chromatid resolution without affecting the timing of DNA replication. Nature Cell Biology. 5(7). 668–674. 85 indexed citations
14.
Taniuchi, Ichiro, Mary Jean Sunshine, Richard Festenstein, & Dan R. Littman. (2002). Evidence for Distinct CD4 Silencer Functions at Different Stages of Thymocyte Differentiation. Molecular Cell. 10(5). 1083–1096. 105 indexed citations
15.
Dillon, Niall & Richard Festenstein. (2002). Unravelling heterochromatin: competition between positive and negative factors regulates accessibility. Trends in Genetics. 18(5). 252–258. 193 indexed citations
16.
Festenstein, Richard & Dimitris Kioussis. (2000). Locus control regions and epigenetic chromatin modifiers. Current Opinion in Genetics & Development. 10(2). 199–203. 65 indexed citations
17.
Sekkali, Belaïd, George Skavdis, Alexander Saveliev, et al.. (1999). Human HMG box transcription factor HBP1: a role in hCD2 LCR function. The EMBO Journal. 18(22). 6396–6406. 51 indexed citations
18.
Festenstein, Richard, Soheila Sharghi-Namini, Margaret Fox, et al.. (1999). Heterochromatin protein 1 modifies mammalian PEV in a dose- and chromosomal-context- dependent manner. Nature Genetics. 23(4). 457–461. 101 indexed citations
19.
Kioussis, Dimitris & Richard Festenstein. (1997). Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals. Current Opinion in Genetics & Development. 7(5). 614–619. 128 indexed citations
20.
Elliott, James I., Richard Festenstein, Mauro Tolaini, & D Kioussis. (1995). Random activation of a transgene under the control of a hybrid hCD2 locus control region/Ig enhancer regulatory element.. The EMBO Journal. 14(3). 575–584. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirohiko Hohjoh Breakdown of academic impact, for papers by Jo Peters Breakdown of academic impact, for papers by Joel Schwartz Breakdown of academic impact, for papers by Giuseppe Merla Breakdown of academic impact, for papers by Hitoshi Miyachi Breakdown of academic impact, for papers by Jean‐Philippe Hugnot Breakdown of academic impact, for papers by Kathleen A. Worringer Breakdown of academic impact, for papers by Marlène Rio Breakdown of academic impact, for papers by Sylvain Briault Breakdown of academic impact, for papers by Nicole J. Francis
Rankless by CCL
2026